Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following best describes the ionization state of a drug when the pH of the environment equals the drug's pKa?

The drug exists as 50% ionized and 50% unionized.. ### Explanation The ionization state of a drug is governed by the **Henderson-Hasselbalch Equation**, which describes the relationship between the pH of the medium, the pKa of the drug, and the ratio of its ionized to unionized forms. **Why Option A is Correct:** The Henderson-Hasselbalch equation is expressed as: * **For Weak Acids:** $pH = pKa + \log \frac{[Ionized]}{[Unionized]}$ * **For Weak Bases:** $pH = pKa + \log \frac{[Unionized]}{[Ionized]}$ When the **pH equals the pKa**, the value of $\log \frac{[Ionized]}{[Unionized]}$ (or vice versa) becomes **zero**. Since $\log(1) = 0$, the ratio of ionized to unionized drug must be **1:1**. Therefore, exactly **50%** of the drug exists in the ionized form and **50%** in the unionized form. **Why Other Options are Incorrect:** * **Options B & C:** These ratios occur when there is a difference between pH and pKa. For instance, a 1-unit difference in pH results in a 10:1 ratio (approx. 90% vs 10%), and a 2-unit difference results in a 100:1 ratio (approx. 99% vs 1%). * **Option D:** A drug is never "completely" ionized in biological systems, though it may approach 99.9% if the pH-pKa gradient is very high. **High-Yield Clinical Pearls for NEET-PG:** 1. **Lipid Solubility:** Only the **unionized** form of a drug is lipid-soluble and can cross biological membranes (e.g., Blood-Brain Barrier, GI tract). 2. **Ion Trapping:** This principle is used in toxicology. To treat **Aspirin (weak acid)** poisoning, we **alkalinize the urine** (using Sodium Bicarbonate). This increases the ionized fraction of the drug in the renal tubules, preventing reabsorption and enhancing excretion. 3. **Memory Aid:** "Like is unionized in like." (Acidic drugs are unionized in acidic pH; Basic drugs are unionized in basic pH).

Q: High continuous doses of agonist drugs cause which of the following?

Down-regulation of receptors. **Explanation:** The correct answer is **A. Down-regulation of receptors.** This phenomenon is a classic example of **receptor regulation**, a homeostatic mechanism the body uses to maintain equilibrium. When a cell is exposed to high, continuous concentrations of an **agonist**, the receptors are overstimulated. To protect the cell from excessive activation, the body reduces the number or sensitivity of these receptors. This occurs through: 1. **Internalization:** Receptors are moved from the cell membrane into the cytoplasm via endocytosis. 2. **Degradation:** Receptors are broken down by lysosomes. 3. **Reduced Synthesis:** Decreased production of new receptor proteins. **Why the other options are incorrect:** * **B. Up-regulation of receptors:** This is the opposite process. It occurs in response to chronic exposure to **antagonists** (blockers) or due to denervation. When receptors are blocked, the cell compensates by increasing the number of receptors to catch any available signal. * **C. Depends on the dose:** While the *extent* of down-regulation is dose-dependent, the *direction* of the physiological response to a continuous agonist is consistently down-regulation. **High-Yield NEET-PG Pearls:** * **Tachyphylaxis:** A rapid form of desensitization (e.g., repeated doses of Ephedrine or Tyramine). * **Tolerance:** A gradual decrease in responsiveness to a drug (e.g., Morphine, Nitrates) often mediated by down-regulation. * **Clinical Consequence:** Sudden withdrawal of an antagonist (like Propranolol) can lead to "rebound hypertension" or angina because the receptors were **up-regulated** during treatment, making the cell hypersensitive to endogenous ligands.

Q: A drug that shifts the dose-response curve to the left has:

More potency. ### Explanation **1. Why "More Potency" is Correct:** Potency refers to the amount of drug (dose) required to produce a specific effect of a given intensity. On a graded dose-response curve (DRC), the x-axis represents the dose/concentration (usually in log scale). When a drug's DRC shifts to the **left**, it indicates that a **lower dose** is required to achieve the same response (e.g., the $ED_{50}$). Therefore, a leftward shift signifies higher potency. **2. Why Other Options are Incorrect:** * **Option A (More Efficacy):** Efficacy is the maximal response ($E_{max}$) a drug can produce. On a DRC, efficacy is represented by the **height (y-axis)** of the curve. A drug with more efficacy would have a taller curve, not necessarily a leftward shift. * **Option C (More Safety):** Safety is typically measured by the **Therapeutic Index** ($LD_{50}/ED_{50}$). A shift to the left only tells us about the drug's power at low doses; it does not provide information about the lethal dose or the margin of safety unless compared with the toxicity curve. **3. NEET-PG High-Yield Pearls:** * **Potency vs. Efficacy:** Efficacy is clinically more important than potency. For example, Furosemide is more efficacious than Chlorothiazide because it can remove more fluid, regardless of the milligram dose used. * **Competitive Antagonists:** These shift the DRC of an agonist to the **right** (increasing $ED_{50}$, decreasing potency) without affecting the maximal response (efficacy). * **Non-competitive Antagonists:** These shift the DRC **downwards**, decreasing the maximal response (efficacy) without necessarily changing the $ED_{50}$ (potency). * **$ED_{50}$ (Median Effective Dose):** The dose at which 50% of the maximal effect is observed. It is the standard measure used to compare the potency of drugs.

Q: Maintenance dose is primarily dependent on which pharmacokinetic parameter?

Clearance. **Explanation:** The primary goal of a **maintenance dose** is to maintain a steady-state plasma concentration ($C_{ss}$) of a drug, where the rate of drug administration equals the rate of drug elimination. **1. Why Clearance (A) is correct:** The mathematical formula for maintenance dose is: $$\text{Maintenance Dose} = \frac{C_{ss} \times \text{Clearance}}{\text{Bioavailability (F)}}$$ Since the dose is intended to replace only the amount of drug lost from the body, it is directly proportional to **Clearance (CL)**. If a patient has impaired clearance (e.g., renal failure), the maintenance dose must be decreased to avoid toxicity. **2. Why other options are incorrect:** * **Volume of Distribution (Vd):** This parameter determines the **Loading Dose**, not the maintenance dose. Vd relates the total amount of drug in the body to the plasma concentration but does not account for the rate of elimination over time. * **Metabolism:** While metabolism is a component of clearance, it is not the only one (excretion also plays a role). Clearance is the more comprehensive pharmacokinetic parameter used for dosing calculations. * **Absorption:** This affects the bioavailability (F) and the peak concentration, but the maintenance dose is calculated based on the target steady-state level regardless of how the drug enters the systemic circulation (though F is used as a correction factor). **Clinical Pearls for NEET-PG:** * **Loading Dose** = $(Vd \times \text{Target } C_{ss}) / F$. Think: *Vd for Loading, Clearance for Maintenance.* * **Steady State:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration. * **Half-life ($t_{1/2}$):** Is determined by both Vd and CL ($t_{1/2} = 0.693 \times Vd / CL$).

Q: Which of the following is NOT a phase I drug metabolism reaction?

Sulfation. Drug metabolism (biotransformation) typically occurs in two phases to make lipophilic drugs more water-soluble for excretion. **Why Sulfation is the correct answer:** **Sulfation** is a **Phase II (Conjugation) reaction**. Phase II reactions involve the attachment of an endogenous hydrophilic group (like glucuronic acid, sulfate, or glutathione) to a drug or its Phase I metabolite. This significantly increases water solubility and usually results in pharmacological inactivation. Other Phase II reactions include Glucuronidation (most common), Acetylation, and Methylation. **Why the other options are incorrect:** Phase I reactions (Functionalization) introduce or expose a functional group (–OH, –NH2, –SH) on the drug molecule. * **Oxidation (Option A):** The most common Phase I reaction, primarily mediated by Cytochrome P450 enzymes. * **Deamination (Option B):** The removal of an amino group from a molecule, a classic Phase I process (e.g., metabolism of adrenaline by MAO). * **Dealkylation (Option C):** The removal of alkyl groups (like methyl or ethyl) from a drug, also a Phase I oxidative process. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Phase II:** **"S-G-A-M"** (Sulfation, Glucuronidation, Acetylation, Methylation). * **Microsomal vs. Non-microsomal:** Most Phase I and Glucuronidation occur in the Smooth ER (microsomal). Sulfation and Acetylation are **non-microsomal** (cytosolic). * **Exception to Inactivation:** Phase II usually inactivates drugs, but **Morphine-6-glucuronide** is a Phase II metabolite that is *more* active than morphine. * **Grey Baby Syndrome:** Occurs due to deficient Glucuronidation of Chloramphenicol in neonates.

Q: All of the following factors tend to increase the volume of distribution of a drug except?

High plasma protein binding. **Explanation:** The **Volume of Distribution ($V_d$)** is a theoretical volume that relates the total amount of drug in the body to its concentration in the plasma ($V_d = \text{Amount of drug} / \text{Plasma concentration}$). A high $V_d$ indicates that the drug has left the vascular compartment and distributed into tissues. **Why Option A is correct:** **High plasma protein binding** (e.g., to albumin) keeps the drug molecules "trapped" within the vascular compartment. Since the drug cannot easily cross capillary membranes while bound to proteins, the plasma concentration remains high, resulting in a **low $V_d$**. Therefore, high plasma protein binding decreases, rather than increases, the $V_d$. **Why the other options are incorrect:** * **B. Low ionization:** Non-ionized drugs are lipid-soluble and can easily cross biological membranes to enter tissues, thereby **increasing $V_d$**. * **C. High lipid solubility:** Lipid-soluble drugs (e.g., Thiopentone) easily cross the blood-brain barrier and cell membranes, distributing extensively into adipose and other tissues, which **increases $V_d$**. * **D. High tissue binding:** Drugs with a high affinity for specific tissue proteins (e.g., Digoxin binding to cardiac muscle) are sequestered outside the plasma, leading to a very **high $V_d$** (often exceeding the total body water). **NEET-PG High-Yield Pearls:** * **Chloroquine** has one of the highest $V_d$ values (~13,000 L) due to extensive tissue binding. * Drugs with **low $V_d$** (e.g., Heparin, Warfarin) are largely confined to the vascular compartment and are easily removed by hemodialysis. * **Loading Dose** calculation is directly dependent on $V_d$ ($\text{LD} = V_d \times \text{Target Plasma Concentration}$).

Q: An acidic drug is more ionized at which pH?

Alkaline pH. **Explanation:** The ionization of a drug depends on its chemical nature (pKa) and the pH of the surrounding medium [1]. This concept is governed by the **Henderson-Hasselbalch equation**. **1. Why Alkaline pH is Correct:** An acidic drug (HA) acts as a proton donor. In an **alkaline (basic) environment**, there is a low concentration of hydrogen ions ($H^+$). To reach equilibrium, the acidic drug dissociates to release $H^+$, becoming negatively charged ($A^-$). Therefore, **acidic drugs are more ionized in alkaline media** and more unionized in acidic media [1]. **2. Why Other Options are Incorrect:** * **Acidic pH:** In an acidic medium, there is an abundance of $H^+$ ions. This suppresses the dissociation of an acidic drug (Le Chatelier's principle), keeping it in its **unionized (lipid-soluble)** form. * **Neutral pH:** While some ionization occurs at pH 7.0, it is not the *maximal* point of ionization for an acidic drug compared to a truly alkaline environment. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Lipid Solubility:** Only the **unionized** form of a drug is lipid-soluble and can cross biological membranes (e.g., GI absorption, Blood-Brain Barrier). * **Ion Trapping:** This principle is used in the **management of drug poisoning** [2]. To accelerate the excretion of an acidic drug (like **Aspirin or Barbiturates**), we **alkalinize the urine** using Sodium Bicarbonate [2]. This "traps" the drug in its ionized form in the renal tubules, preventing reabsorption. * **Mnemonic:** *"Like dissolves in Like"* (Acidic drugs are unionized/absorbed in acidic media; Basic drugs are unionized/absorbed in basic media).

Q: Which of the following reactions is NOT catalyzed by microsomal enzymes?

Acetylation. Drug metabolism is divided into Phase I (Functionalization) and Phase II (Conjugation) reactions. These are catalyzed by enzymes located either in the **microsomes** (smooth endoplasmic reticulum) or the **cytoplasm/mitochondria** (non-microsomal). **Why Acetylation is the correct answer:** Acetylation is a Phase II conjugation reaction catalyzed by the enzyme **N-acetyltransferase (NAT)**. Unlike most other conjugation reactions, NAT is a **non-microsomal enzyme** located in the cytoplasm of hepatocytes and other tissues [1]. Therefore, it does not require the microsomal cytochrome P450 system. **Analysis of Incorrect Options:** * **Glucuronidation (Option A):** This is the **only** Phase II reaction catalyzed by microsomal enzymes (specifically UDP-glucuronosyltransferases or UGTs) [1, 2]. It is the most common conjugation pathway. * **Oxidation (Option B):** Most Phase I oxidative reactions (e.g., hydroxylation, dealkylation) are catalyzed by the microsomal **Cytochrome P450** monooxygenase system [1]. * **Reduction (Option C):** Many reductive reactions (e.g., chloramphenicol metabolism) are carried out by microsomal enzymes, though some can occur non-microsomally. **High-Yield NEET-PG Pearls:** 1. **Phase II Rule:** All Phase II reactions are non-microsomal **EXCEPT** Glucuronidation. 2. **Phase I Rule:** Most Phase I reactions are microsomal **EXCEPT** those involving Alcohol Dehydrogenase (cytosol), MAO (mitochondria), and Xanthine Oxidase. 3. **Acetylation Polymorphism:** This is clinically significant for drugs like **Isoniazid, Hydralazine, and Procainamide** (Mnemonic: **SHIP** - Sulfonamides, Hydralazine, Isoniazid, Procainamide). "Slow acetylators" are at higher risk of toxicity (e.g., peripheral neuropathy with Isoniazid or SLE with Hydralazine). 4. **Microsomal Induction:** Microsomal enzymes are inducible by drugs like Phenobarbitone and Rifampicin, whereas non-microsomal enzymes are generally non-inducible.

Q: Receptors are located in the nucleus for all of the following except?

Insulin. **Explanation:** The location of a drug receptor is primarily determined by the chemical nature of the ligand. Receptors for lipid-soluble substances are located intracellularly, while receptors for water-soluble substances are located on the cell membrane. **1. Why Insulin is the Correct Answer:** Insulin is a large, water-soluble peptide hormone. It cannot cross the lipid bilayer of the cell membrane. Therefore, it binds to **transmembrane receptors** (specifically, **Tyrosine Kinase receptors**) located on the cell surface. Once insulin binds to the alpha subunit, it triggers autophosphorylation of the intracellular beta subunit to initiate a signaling cascade. **2. Why the other options are incorrect:** * **Thyroxine (T4/T3):** Although derived from amino acids, thyroid hormones are transported into the cell and bind to high-affinity **nuclear receptors** (TR-α and TR-β) that act as ligand-activated transcription factors. * **Vitamin D (Calcitriol):** As a steroid-like derivative, Vitamin D crosses the membrane and binds to the **Vitamin D Receptor (VDR)** in the nucleus, regulating calcium-binding protein synthesis. * **Vitamin A (Retinoic Acid):** Retinoids bind to **Retinoic Acid Receptors (RAR)** and **Retinoid X Receptors (RXR)** located within the nucleus to modulate gene expression. **High-Yield Clinical Pearls for NEET-PG:** * **Nuclear Receptors (Mnemonic: "T3, T4, Vit A, D, and Steroids"):** These include Thyroid hormones, Vitamin A, Vitamin D, and Steroid hormones (Glucocorticoids, Estrogen, Progesterone). * **Cytoplasmic Receptors:** Classically, Glucocorticoid and Mineralocorticoid receptors are found in the cytoplasm before translocating to the nucleus. * **Fastest vs. Slowest:** Ionotropic receptors (e.g., GABA-A) act in milliseconds, while Nuclear receptors are the slowest, taking hours to days to show effects due to gene transcription.

Question 1

Which of the following best describes the ionization state of a drug when the pH of the environment equals the drug's pKa?

Accepted Answer

The drug exists as 50% ionized and 50% unionized.

Answer

The drug exists as 25% ionized and 75% unionized.

Answer

The drug exists as 75% ionized and 25% unionized.

Answer

The drug is completely ionized.

Question 2

In an alcoholic individual, tolerance to alcohol that disappears as rapidly as it develops is known as:

Accepted Answer

Pharmacokinetic tolerance

Answer

Cellular tolerance

Answer

Pharmacodynamic tolerance

Answer

Behavioural tolerance

Question 3

High continuous doses of agonist drugs cause which of the following?

Accepted Answer

Down-regulation of receptors

Answer

Up-regulation of receptors

Answer

Depends on the dose

Answer

None of the above

Question 4

A drug that shifts the dose-response curve to the left has:

Accepted Answer

More potency

Answer

More efficacy

Answer

More safety

Answer

None of the above

Question 5

Maintenance dose is primarily dependent on which pharmacokinetic parameter?

Accepted Answer

Clearance

Answer

Volume of distribution

Answer

Metabolism

Answer

Absorption

Question 6

Which of the following is NOT a phase I drug metabolism reaction?

Accepted Answer

Sulfation

Answer

Oxidation

Answer

Deamination

Answer

Dealkylation

Question 7

All of the following factors tend to increase the volume of distribution of a drug except?

Accepted Answer

High plasma protein binding

Answer

Low ionization at physiological pH values

Answer

High lipid solubility

Answer

High tissue binding

Question 8

An acidic drug is more ionized at which pH?

Accepted Answer

Alkaline pH

Answer

Acidic pH

Answer

Neutral pH

Answer

None of the above

Question 9

Which of the following reactions is NOT catalyzed by microsomal enzymes?

Accepted Answer

Acetylation

Answer

Glucuronidation

Answer

Oxidation

Answer

Reduction

Question 10

Receptors are located in the nucleus for all of the following except?

Accepted Answer

Insulin

Answer

Vitamin D

Answer

Thyroxine

Answer

Vitamin A

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?